Metabolism of vitamin B-6 and its requirement in chronic renal failure

被引:0
|
作者
Mydlik, M [1 ]
Derzsiova, K [1 ]
Zemberova, E [1 ]
机构
[1] UNIV HOSP LOUIS PASTEUR,CLIN NUCL MED,KOSICE 04190,SLOVAKIA
关键词
vitamin B6; renal failure; pyridoxine; furosemide;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Vitamin B-6 is very important for the normal function of multiple organ systems. In the majority of patients with chronic renal failure and in patients Juring various forms of renal replacement therapy can develop vitamin B-6 deficiency from many causes. Intravenous administration of 20 mg furosemide led to the increase of urinary excretion and fraction excretion (FE) of vitamin B-6 in patients with chronic renal failure. This is a new side effect of furosemide. The daily oral dose of pyridoxine 6 mg was optimal for the patients without erythropoietin (EPO) treatment during the period of 12 months of CAPD. Erythrocyte vitamin B-6 was determined by an indirect method, that is, by measuring the effect of pyridoxal-5-phosphate (PLP). In the other group of CAPD patients plasma vitamin B-6 was in the reference range. and the mean Value of peritoneal clearance of vitamin B-6 was very low: 8.8% of urea clearance. In addition, an indirect relationship between the effect of PLP and plasma vitamin B-6 was found. Indirect evidence has shown that erythrocyte vitamin B-6 is consumed by the hemoglobin synthesis much more during EPO treatment in hemodialysis patients. No influence of pyridoxine 5 to 6 mg/day on decreased parameters of cellular immunity was found. For prevention of vitamin B-6 deficiency in hemodialysis and CAPD patients we recommend the following doses of pyridoxine: for patients without EPO treatment 5 mg/day, and with EPO treatment 20 mg/day. A favorable effect of pyridoxine 50 mg/day has also been found on several parameters of cellular immunity in hemodialysis patients.
引用
收藏
页码:S56 / S59
页数:4
相关论文
共 50 条
  • [21] Bioavailability of vitamin B-6
    Gregory, JF
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1997, 51 : S43 - S48
  • [22] Synthetic vitamin B-6
    Harris, SA
    Folkers, K
    SCIENCE, 1939, 89 : 347 - 347
  • [23] Synthesis of vitamin B-6
    Harris, SA
    Folkers, K
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1939, 61 : 1245 - 1247
  • [24] Crystalline vitamin B-6
    Keresztesy, JC
    Stevens, JR
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1938, 38 (01): : 64 - 65
  • [25] Toxicity of vitamin B-6
    Unna, K
    Antopol, W
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1940, 43 (01): : 116 - 118
  • [26] Vitamin B-6 (adermin)
    不详
    BRITISH MEDICAL JOURNAL, 1941, 1941 : 166 - 167
  • [27] Vitamin D metabolism in chronic renal failure
    Gallieni, M
    Cozzolino, M
    Brancaccio, D
    ITALIAN JOURNAL OF MINERAL & ELECTROLYTE METABOLISM, 1995, 9 (02): : 67 - 72
  • [28] The significance of tryptophan metabolism and vitamin B-6 status in cardiovascular disease
    Gostner, Johanna Maria
    Kurz, Katharina
    Fuchs, Dietmar
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2020, 111 (01): : 8 - 9
  • [29] Clinical use of cyclooxygenase inhibitors impairs vitamin B-6 metabolism
    Chang, Hsin-Yueh
    Tang, Feng-Yao
    Chen, Der-Yuan
    Chih, Hui-Min
    Huang, Shih-Ting
    Cheng, Hung-Dian
    Lan, Joung-Liang
    Chiang, En-Pei Isabel
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2013, 98 (06): : 1440 - 1449